[1]任树军 于长江 梁彦林 杜海月 李远峰 徐西林△.生髓健骨胶囊对酒精性骨质疏松大鼠血清学指标的影响[J].中国中医骨伤科杂志,2021,29(07):21-24.
　REN Shujun YU Changjiang LIANG Yanlin DU Haiyue LI Yuanfeng XU Xilin.Efficacy of Shengsui Jiangu Capsule on Serum Ca, P, ALP and BGP in Rats with Alcoholic Osteoporosis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2021,29(07):21-24.
点击复制

生髓健骨胶囊对酒精性骨质疏松大鼠血清学指标的影响()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第29卷
期数:
2021年07期
页码:
21-24
栏目:
实验研究
出版日期:
2021-07-15

文章信息/Info

Title:
Efficacy of Shengsui Jiangu Capsule on Serum Ca, P, ALP and BGP in Rats with Alcoholic Osteoporosis
文章编号:
1005-0205(2021)07-0021-04
作者:
任树军1 于长江2 梁彦林3 杜海月2 李远峰1 徐西林4△
1黑龙江中医药大学附属第一医院(哈尔滨,150040)2黑龙江中医药大学研究生院3宁夏中医医院暨中医研究院4黑龙江中医药大学附属第二医院
Author(s):
REN Shujun1 YU Changjiang2 LIANG Yanlin3 DU Haiyue2 LI Yuanfeng1 XU Xilin4△
1The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040,China; 2Graduate School of Heilongjiang University of Chinese Medicine, Harbin 150040,China; 3 Ningxia Hospital and Research Institute of Chinese Medicine, Yinchuan 750021,China; 4The Second Affiliated Hospital of Heilongjiang University of Chinese medicine, Harbin 150001,China.
关键词:
生髓健骨胶囊;  酒精性骨质疏松;  血清生化指标
Keywords:
Shengsui Jiangu capsule;  alcoholic osteoporosis;  serum biochemical indexes
分类号:
R-33
文献标志码:
A
摘要:
目的:研究生髓健骨胶囊对酒精性骨质疏松大鼠血清钙(Ca)、磷(P)、碱性磷酸酶(ALP)及骨钙素(BGP)生化指标的影响。方法:120只SD大鼠,随机分成四组:模型组、空白对照组、西药对照组、中药干预组,每组各30只,用白酒灌胃造模,同时给予生髓健骨胶囊和0.9%NaCl注射液、碳酸钙片与阿法D3和0.9%NaCl注射液分别配制成混悬液灌胃。干预8、12、16 周后取材,用全自动生化分析仪测定血清钙、磷、碱性磷酸酶的含量,并用RIA法测定骨钙素含量。结果:模型组与空白对照组相比,血清Ca、P、ALP及BGP明显降低,差异有统计学意义(P<0.01)。西药对照组、中药干预组血清Ca、P、ALP及BGP高于模型组,差异有统计学意义(P<0.01)。中药干预组效果优于西药对照组,差异有统计学意义(P<0.05)。结论:生髓健骨胶囊具有提高血清钙、磷、碱性磷酸酶及骨钙素含量,起到防治酒精性骨质疏松的作用。
Abstract:
To study the efficacy of Shengsui Jiangu capsule on serum calcium(Ca), phosphorus(P), alkaline phosphatase(ALP)and Osteocalcin(BGP)biochemical indexes in rats with alcoholic osteoporosis.Methods: 120 SD rats were randomly divided into four groups:model group, blank control group, western medicine control group and traditional Chinese medicine intervention group, with 30 rats in each group.The model was established by intragastric administration of liquor.The blank control group was established by intragastric administration of 0.9% NaCl liquor.The western medicine control group was established by intragastric administration of alcium carbonate tablets and Alfa D3 and 0.9% NaCl injection liquor.The traditional Chinese medicine intervention group was established by intragastric administration of Shengsui Jiangu capsule and 0.9% NaCl injection liquor.After 8, 12 and 16 weeks of intervention, serum calcium, phosphorus and alkaline phosphatase were measured by automatic biochemical analyzer, and osteocalcin was measured by RIA.Results: Compared with the blank control group, serum Ca, P, ALP and BGP in the model group were significantly decreased(P<0.01).Serum Ca, P, ALP and BGP in western medicine control group and Chinese medicine intervention group were higher than those in model group(P<0.01).The efficacy of traditional Chinese medicine intervention group was better than that of western medicine control group(P<0.05), with statistical significance.Conclusion: Shengsui Jiangu capsule can improve the content of serum calcium, phosphorus, alkaline phosphatase and osteocalcin, and prevent and treat alcoholic osteoporosis.

参考文献/References:

[1] 李雪,申意伟,徐西林,等.补肾活血方治疗酒精性骨质疏松症临床疗效观察[J].辽宁中医药大学学报,2019,21(9):196-198.
[2] 蔡晓燕,董光富.脂代谢及血清骨钙素水平与骨质疏松症的相关性分析[J].中国骨质疏松杂志,2016,22(6):711-712.
[3] 齐振熙,王明千.酒精性骨质疏松症的动物模型研究[J].中国骨伤,2005,18(12):735-736.
[4] 郭鱼波,马如风,王丽丽,等.骨质疏松动物模型及其评价方法的研究进展[J].中国骨质疏松杂志,2015,21(9):1149-1154.
[5] 王志超,李志毅.鹿角胶丸对骨质疏松模型大鼠影响的实验研究[J].中医正骨,2003,15(11):16-17.
[6] 马少华,马勇.中药治疗原发性骨质疏松症效应机制研究进展[J].中国骨质疏松杂志,2014,20(12):1490-1494.
[7] 赵金龙,曾令烽,梁桂洪,等.基于信号通路的中药有效成分治疗骨质疏松机制研究进展[J].中草药,2020,51(23):6087-6088.
[8] 董群伟,陈志峰,孙奋勇.牛膝脱皮甾酮促进去卵巢大鼠间充质干细胞的增殖[J].广东医学,2010,31(1):61-63.
[9] 翁绳健,吴立忠,李炜明,等.肾虚与骨质疏松症关联性研究进展[J].中国中医骨伤科杂志,2018,26(12):85-87.
[10] 胡志俊,王世伟,刘文波,等.骨质疏松的中医辨证分型研究[J].中国中医骨伤科杂志,2012,20(1):24-25.
[11] 任树军,梁彦林,任明辉,等.生髓健骨胶囊对酒精性骨质疏松大鼠股骨生物力学影响的研究[J].中国骨质疏松杂志,2018,24(10):1289-1293.
[12] 任树军,梁彦林,姜磊,等.生髓健骨胶囊对酒精性骨质疏松大鼠骨密度、骨矿含量影响的研究[J].中国骨质疏松杂志,2019,25(5):638-641.
[13] 任树军,梁彦林,王墉琦,等.生髓健骨胶囊对酒精性骨质疏松大鼠Wnt信号通路的影响[J].时珍国医国药,2020,31(3):579-581.
[14] 沈英,梁世凯.维持性血液透析患者发生骨质疏松的危险因素及其与血清钙、磷、甲状旁腺素的关系[J].中华全科医学,2017,15(11):1902-1903.
[15] 丁霏,陈彦丽,廖静,等.甲状旁腺素、25-羟维生素D及血清钙磷与原发性骨质疏松症的相关性分析[J].国际检验医学杂志,2020,41(6):649-651.
[16] 郭应龙.老年男性骨质疏松患者血清胰岛素样生长因子、内皮素与骨钙素及骨转换生化指标的相关性研究[J].中国骨质疏松杂志,2015,21(2):132-134.
[17] 张延英,尤华琴.老年糖尿病骨质疏松性骨折患者血清生化指标的变化[J].中国老年学杂志,2020,40(4):723-724.
[18] 杨锋,孙玉华,刘佃滨,等.骨质疏松患者骨碱性磷酸酶、钙、磷代谢变化及与牙槽骨骨密度的相关性[J].中国骨质疏松杂志,2017,23(9):1164-1165.
[19] 马远征,王以朋,刘强,等.中国老年骨质疏松诊疗指南(2018)[J].中国老年学杂志,2019,39(11):2565-2566.

备注/Memo

备注/Memo:
基金项目:黑龙江省自然科学基金项目(LH2020H086)黑龙江省中医药管理局项目(ZHY10-W22 )
△通信作者 E-mail:15244603358@163.com
更新日期/Last Update: 2021-07-15